KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Total Debt (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Total Debt for 13 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • Quarterly Total Debt fell 68.65% to $5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Dec 2025, down 68.65% year-over-year, with the annual reading at $5.0 million for FY2025, 68.65% down from the prior year.
  • Total Debt for Q4 2025 was $5.0 million at Biolife Solutions, down from $7.5 million in the prior quarter.
  • The five-year high for Total Debt was $27.0 million in Q1 2023, with the low at $916000.0 in Q1 2021.
  • Average Total Debt over 5 years is $15.3 million, with a median of $14.4 million recorded in 2024.
  • The sharpest move saw Total Debt plummeted 94.82% in 2021, then soared 991.38% in 2022.
  • Over 5 years, Total Debt stood at $7.2 million in 2021, then soared by 254.91% to $25.6 million in 2022, then decreased by 6.88% to $23.8 million in 2023, then crashed by 33.15% to $15.9 million in 2024, then plummeted by 68.65% to $5.0 million in 2025.
  • According to Business Quant data, Total Debt over the past three periods came in at $5.0 million, $7.5 million, and $10.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.